Plain-English translation of NCT05636709 on ClinicalTrials.gov ↗ ·
This is a real-world study of Adacolumn GMA, a treatment that filters certain immune cells from your blood to help reduce inflammation in inflammatory bowel disease. The study will follow about 350 patients across Spain to see how well this medication works when used in regular doctor's offices and clinics, and how it affects your quality of life over 12 months.
Doctors want to understand how this treatment performs in actual clinical practice — not just in controlled research settings — and whether it can help reduce steroid use and improve symptoms for people with Crohn's disease or ulcerative colitis.
You likely qualify if…
You likely don't qualify if…
You will receive the blood filtering treatment according to your doctor's plan — typically one session per week for 5 weeks, though your doctor may adjust this based on your needs. You will have four study visits: at the start, and then at 1 month, 6 months, and 12 months after your treatment ends. These visits will be scheduled during your regular clinic appointments, so they won't add extra trips to the hospital.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain